Digest Network Come funziona
Network
/
Società
IC
Non verificato

ICPO Foundation

Di cosa scriviamo

MediaMedicina - VarieMedicina Salute BenesserePubblicità/Marketing/Media/ComunicazioneScienza

9 comunicati stampa

Guarda tutti i comunicati
09/10/2025
Medicina Salute Benessere
ICPO Foundation welcomes 24 new ICPO Theranostics Clinical Centers of Excellence to its global network of 45 centers
Fonte
ICPO Foundation
Emittente
GLOBENEWSWIRE
1.00
0
31/07/2025
Medicina Salute Benessere
ICPO and SBMN deepen their collaboration to advance Clinical Theranostics Centers of Excellence in Brazil
Fonte
ICPO Foundation
Emittente
GLOBENEWSWIRE
1.00
0
21/06/2025
Medicina Salute Benessere
Annunci Economici
ICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients
Fonte
ICPO Foundation
Emittente
GLOBENEWSWIRE
1.00
0
26/05/2025
Medicina Salute Benessere
ICPO Forum 2025: Advancing Theranostics in Precision Oncology
Fonte
ICPO Foundation
Emittente
GLOBENEWSWIRE
1.00
0
12/12/2024
Medicina Salute Benessere
5th Anniversary: ICPO Foundation is empowering a new era of cancer treatment with Radiotheranostics for patients worldwide
Fonte
ICPO Foundation
Emittente
GLOBENEWSWIRE
1.00
0
27/11/2024
Medicina Salute Benessere
The ICPO Theranostics Virtual Summit 2024 presented today's and tomorrow's clinical relevance of radiotheranostics in oncology
Fonte
ICPO Foundation
Emittente
GLOBENEWSWIRE
1.00
0
18/11/2024
Medicina Salute Benessere
ICPO Foundation partners with Munich Precision Oncology (MPO) to establish dedicated theranostics centers globally
Fonte
ICPO Foundation
Emittente
GLOBENEWSWIRE
1.00
0
16/10/2024
Medicina Salute Benessere
Pubblicità/Marketing/Media/Comunicazione
ICPO Foundation funded global “Radiopharmaceutical Trial Finder” developed by WARMTH and Ancora.ai
Fonte
ICPO Foundation
Emittente
GLOBENEWSWIRE
1.00
0
10/10/2024
Medicina Salute Benessere
ICPO Foundation partners with the International Atomic Energy Agency (IAEA)
Fonte
ICPO Foundation
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0